ONCOLOGY, NUCLEAR MEDICINE AND TRANSPLANTOLOGY
Abstract
Oct 03, 2025 2 2

Influence of Immunophenotypic Characteristics of Plasma Cells in Multiple Myeloma Patients on Disease Prognosis and Course

A. B. Karabekov 1 * ,
V. M. Kemaykin 1,
Zh. A. Iskakova 1,
R. B. Ibragimova 1
1 National Research Oncology Center LLP, Astana, Republic of Kazakhstan* Corresponding Author
Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), 2025, onmt_A9
Publication date: Oct 03, 2025
Full Text (PDF)

ABSTRACT

---

KEYWORDS

---

CITATION (Vancouver)

Karabekov AB, Kemaykin VM, Iskakova ZA, Ibragimova RB. Influence of Immunophenotypic Characteristics of Plasma Cells in Multiple Myeloma Patients on Disease Prognosis and Course. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1):onmt_A9.
APA
Karabekov, A. B., Kemaykin, V. M., Iskakova, Z. A., & Ibragimova, R. B. (2025). Influence of Immunophenotypic Characteristics of Plasma Cells in Multiple Myeloma Patients on Disease Prognosis and Course. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A9.
Harvard
Karabekov, A. B., Kemaykin, V. M., Iskakova, Z. A., and Ibragimova, R. B. (2025). Influence of Immunophenotypic Characteristics of Plasma Cells in Multiple Myeloma Patients on Disease Prognosis and Course. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A9.
AMA
Karabekov AB, Kemaykin VM, Iskakova ZA, Ibragimova RB. Influence of Immunophenotypic Characteristics of Plasma Cells in Multiple Myeloma Patients on Disease Prognosis and Course. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1), onmt_A9.
Chicago
Karabekov, A. B., V. M. Kemaykin, Zh. A. Iskakova, and R. B. Ibragimova. "Influence of Immunophenotypic Characteristics of Plasma Cells in Multiple Myeloma Patients on Disease Prognosis and Course". Oncology, Nuclear Medicine and Transplantology 2025 1 no. Suppl. 1 (2025): onmt_A9.
MLA
Karabekov, A. B. et al. "Influence of Immunophenotypic Characteristics of Plasma Cells in Multiple Myeloma Patients on Disease Prognosis and Course". Oncology, Nuclear Medicine and Transplantology, vol. 1, no. Suppl. 1, 2025, onmt_A9.

REFERENCES

---

LICENSE

Creative Commons License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.